Literature DB >> 6805675

Cyclophosphamide treatment of systemic lupus erythematosus: risk of bladder cancer exceeds benefit.

J A Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6805675      PMCID： PMC1498597          DOI： 10.1136/bmj.284.6330.1710-d

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  6 in total

1.  Second neoplasm--a complication of cancer chemotherapy.

Authors:  B A Chabner
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

2.  Bladder toxicity with chronic oral cyclophosphamide therapy in nonmalignant disease.

Authors:  R G Aptekar; J P Atkinson; J L Decker; S M Wolff; E W Chu
Journal:  Arthritis Rheum       Date:  1973 Jul-Aug

3.  Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.

Authors:  S M Sieber; R H Adamson
Journal:  Adv Cancer Res       Date:  1975       Impact factor: 6.242

Review 4.  Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.

Authors:  E C Cadman; R L Capizzi; J R Bertino
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

5.  Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.

Authors:  B M Bryant; M Jarman; H T Ford; I E Smith
Journal:  Lancet       Date:  1980-09-27       Impact factor: 79.321

6.  Cyclophosphamide-induced hemorrhagic cystitis in children with leukemia.

Authors:  H J Lawrence; J Simone; R J Aur
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.